To explore the bioactivity of CXCR4 in the pathogenesis of POAG, we first analyzed CXCR4 expression levels in trabecular and iris specimens from 54 POAG patients and 19 non-glaucomatous donors (Fig 1A). This evidence concerns the gene CXCR4 and open-angle glaucoma.